The high sensitivity and specificity of this assay demonstrate its utility as a tool for the detection and monitoring of EGFR mutations in NSCLC patients to inform clinical management, especially in cases where tissue biopsies are not readily available. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.